Skip to content

Drug interactions

Rolapitant + Valbenazine

Severity: Moderate

Rolapitant and Valbenazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rolapitant is a prolonged CYP2D6 inhibitor and may raise exposure to the active metabolite of valbenazine, which is partly cleared by CYP2D6. This may increase somnolence and QT prolongation risk.

What this interaction means in plain words

Rolapitant and Valbenazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Rolapitant belongs to Gastrointestinal Tract; Valbenazine belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Rolapitant inhibits CYP2D6, reducing clearance of the active metabolite of valbenazine.

What to do

Monitor for sedation and QT effects, and consider a valbenazine dose reduction if adverse effects occur. The inhibitory effect of rolapitant can last at least 28 days.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rolapitant and Valbenazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Rolapitant with Valbenazine?

MediHelp rates the interaction as moderate. Rolapitant and Valbenazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rolapitant is a prolonged CYP2D6 inhibitor and may raise exposure to the active metabolite of valbenazine, which is partly cleared by CYP2D6. This may increase somnolence and QT prolongation risk.

How serious is the interaction between Rolapitant and Valbenazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for sedation and QT effects, and consider a valbenazine dose reduction if adverse effects occur. The inhibitory effect of rolapitant can last at least 28 days.

What other medicines interact with Rolapitant?

MediHelp also lists interactions of Rolapitant with, for example, Pimozide, Thioridazine, Atomoxetine. The full list is on the Rolapitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in